Major findings from the current study include: 1) TRPM7 mRNA expression is significantly increased in anaplastic astrocytoma, diffuse astrocytoma, and GBM patients compared to that in healthy brain tissue controls. This evidence concerns the gene TRPM7 and glioblastoma.